Cirrhosis News and Research

Latest Cirrhosis News and Research

HCV screening or diagnosis could lower non‐prescribed opioid use

Research presented this week at The Liver Meeting – held by the American Association for the Study of Liver Diseases – shows people in treatment for opioid substance abuse significantly lowered their non‐prescribed opioid use after testing positive for hepatitis C virus.

20 Oct 2017

Liver cirrhosis mortality found to be greater than that of five major cancers

A new study presented this week at The Liver Meeting – held by the American Association for the Study of Liver Diseases – found that liver cirrhosis mortality is greater than that of five major cancers, implying the development of appropriate interventions to treat or prevent liver cirrhosis must be prioritized.

20 Oct 2017

Study finds rise in pregnancy rates among women with chronic liver disease

A new study presented this week at The Liver Meeting – held by the American Association for the Study of Liver Diseases – found that the overall number of pregnancies in women with chronic liver disease or following liver transplantation has risen over the past 30 years.

20 Oct 2017

Common acid reflux drugs linked to progression of chronic liver disease

Approximately 10 percent of the general population take a proton pump inhibitor (PPI) drug to block stomach acid secretions and relieve symptoms of frequent heartburn, acid reflux and gastroesophageal reflux disease.

10 Oct 2017

Experts call for greater focus on effective screening methods to help save lives from digestive cancers

Experts from United European Gastroenterology (UEG), presenting at the European Digestive Cancer Days Conference in Prague today, are calling on European governments to focus their efforts on developing early diagnosis techniques, in order to save thousands of lives from digestive cancers including a more targeted approach to ensure at risk patients don’t ‘slip through the early-detection net’.

28 Sep 2017

Drinking three or more cups of coffee a day linked to reduced mortality risk in HIV-HCV patients

Patients infected by both human immunodeficiency virus (HIV) and hepatitis C virus (HCV) are at specific risk of end-stage liver disease and greater risk of cardiovascular diseases and cancer.

25 Sep 2017

Diet plus alcohol may play key role in liver injury development

A new study published in Alcohol and Alcoholism finds that mice bred to consume high amounts of alcohol, but controlled by diet, did not necessarily develop the most severe liver injuries, suggesting that diet may pay an important role in liver injury development.

25 Sep 2017

EHR-based prompt in primary care increases HCV screening rates among baby boomers

In a recent study, screening rates for hepatitis C virus (HCV) infection among baby boomers increased fivefold in the year following implementation of an electronic health record (EHR)-based prompt for primary care physicians.

14 Sep 2017

Drugs used for treatment of high cholesterol may benefit patients with cirrhosis

Statins used for the treatment of high cholesterol may have other beneficial effects, but there has been reluctance to prescribe them to patients with liver disease because of concerns that they may cause abnormal liver enzyme levels in the blood.

11 Sep 2017

Researchers compare outcomes of liver resection with transplantation for hepatocellular cancers

Liver transplantation is the gold standard for treating early hepatocellular cancers. Because of the lack of donors, this option is, however, available to a limited degree only.

8 Sep 2017

Researchers find signaling pathway in cells that plays key role in development of fatty liver disease

Morbid obesity affects the liver: Almost one-third of all adults suffer from chronic fatty liver disease, which can lead to infections and even trigger cancer. Researchers at the University Children's Hospital Zurich and the University of Zurich have now found a signaling pathway in cells that play an important role in the development of fatty liver disease.

7 Sep 2017

Increased enzyme production by the liver causes fatty liver, obesity and insulin resistance

In mice that are given a high-fat diet, an increased production of the enzyme DPP4 by the liver promotes an increase in body fat, the development of fatty liver disease and insulin resistance.

24 Aug 2017

Pork products associated with carrying hepatitis E virus in Britain

Pork products that are being sold at a leading supermarket has been associated with carrying a deadly hepatitis virus warns the researchers at the Public Health England (PHE).

20 Aug 2017

Altered secretion behavior of fatty liver can lead to damage of other organs

Nonalcoholic fatty liver disease is becoming more and more common. Approximately every third adult in the industrialized countries has a morbidly fatty liver.

18 Aug 2017

Experimental drug protects mice from obesity-related liver disease

A drug developed at the University of Rochester Medical Center protected mice from one of the many ills of our cheeseburger and milkshake-laden Western diet -- non-alcoholic fatty liver disease.

3 Aug 2017

FDA approves new treatment for all HCV genotypes 1-6

The U.S. Food and Drug Administration today approved Mavyret (glecaprevir and pibrentasvir) to treat adults with chronic hepatitis C virus (HCV) genotypes 1-6 without cirrhosis (liver disease) or with mild cirrhosis, including patients with moderate to severe kidney disease and those who are on dialysis.

3 Aug 2017

FDA approves new combo drug Mavyret for adults with Hepatitis C infection

Yesterday the U.S. Food and Drug Administration gave its approval to Mavyret (glecaprevir and pibrentasvir) for the treatment of adults with chronic hepatitis C infection. These patients are infected with the Hepatitis C virus (HCV) of genotypes 1-6 and are those that have not developed liver cirrhosis or those who have developed mild cirrhosis. The approval for Mavyret was given to AbbVie Inc.

3 Aug 2017

U.S. FDA approves updated labeling for pan-genotypic single tablet regimen for HCV/HIV co-infected patients

Gilead Sciences, Inc. today announced that the U.S. Food and Drug Administration has approved updated labeling for Epclusa (sofosbuvir 400mg/velpatasvir 100mg), the first all-oral, pan-genotypic, once-daily single tablet regimen (STR) for the treatment of adults with chronic hepatitis C virus (HCV) infection, to include use in patients co-infected with HIV.

1 Aug 2017

ECDC highlights need to scale-up efforts for eliminating viral hepatitis in Europe

An estimated 4.7 million Europeans are living with chronic hepatitis B and almost 4 million (3.9) with chronic hepatitis C infection.

26 Jul 2017

Men with hepatitis B more likely to develop severe liver disease despite lifestyle choices

Why men with hepatitis B remain more than twice as likely to develop severe liver disease than women remains a mystery, even after a study led by a recent Drexel University graduate took lifestyle choices and environments into account.

25 Jul 2017

Cirrhosis News and Research

Latest Cirrhosis News and Research

HCV screening or diagnosis could lower non‐prescribed opioid use

Liver cirrhosis mortality found to be greater than that of five major cancers

Study finds rise in pregnancy rates among women with chronic liver disease

Common acid reflux drugs linked to progression of chronic liver disease

Experts call for greater focus on effective screening methods to help save lives from digestive cancers

Drinking three or more cups of coffee a day linked to reduced mortality risk in HIV-HCV patients

Diet plus alcohol may play key role in liver injury development

EHR-based prompt in primary care increases HCV screening rates among baby boomers

Drugs used for treatment of high cholesterol may benefit patients with cirrhosis

Researchers compare outcomes of liver resection with transplantation for hepatocellular cancers

Researchers find signaling pathway in cells that plays key role in development of fatty liver disease

Increased enzyme production by the liver causes fatty liver, obesity and insulin resistance

Pork products associated with carrying hepatitis E virus in Britain

Altered secretion behavior of fatty liver can lead to damage of other organs

Experimental drug protects mice from obesity-related liver disease

FDA approves new treatment for all HCV genotypes 1-6

FDA approves new combo drug Mavyret for adults with Hepatitis C infection

U.S. FDA approves updated labeling for pan-genotypic single tablet regimen for HCV/HIV co-infected patients

ECDC highlights need to scale-up efforts for eliminating viral hepatitis in Europe

Men with hepatitis B more likely to develop severe liver disease despite lifestyle choices

Forensics and toxicology - Industry Focus eBook eBook

Evolving spectrophotometry for modern biopharma workflows

Scaling B-cell cloning workflows for antibody development

Fluidics in Modern Healthcare & Medical Device Innovation

Cirrhosis News and Research

Latest Cirrhosis News and Research

Forensics and toxicology - Industry Focus eBook eBook

Evolving spectrophotometry for modern biopharma workflows

Scaling B-cell cloning workflows for antibody development

Fluidics in Modern Healthcare & Medical Device Innovation

Newsletters you may be interested in